APA (7th ed.) Citation

Haag, G. M., Springfeld, C., Grün, B., Apostolidis, L., Zschäbitz, S., Dietrich, M., . . . Jäger, D. (2022). Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer: The PICCASSO phase I trial. European journal of cancer, 167, . https://doi.org/10.1016/j.ejca.2022.03.017

Chicago Style (17th ed.) Citation

Haag, Georg Martin, et al. "Pembrolizumab and Maraviroc in Refractory Mismatch Repair Proficient/microsatellite-stable Metastatic Colorectal Cancer: The PICCASSO Phase I Trial." European Journal of Cancer 167 (2022). https://doi.org/10.1016/j.ejca.2022.03.017.

MLA (9th ed.) Citation

Haag, Georg Martin, et al. "Pembrolizumab and Maraviroc in Refractory Mismatch Repair Proficient/microsatellite-stable Metastatic Colorectal Cancer: The PICCASSO Phase I Trial." European Journal of Cancer, vol. 167, 2022, https://doi.org/10.1016/j.ejca.2022.03.017.